Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Sep 15;326(1-2):3-7.
doi: 10.1016/j.mce.2010.04.027. Epub 2010 May 6.

PRKAR1A and the evolution of pituitary tumors

Lawrence S Kirschner  1
Affiliations
Review

PRKAR1A and the evolution of pituitary tumors

Lawrence S Kirschner. Mol Cell Endocrinol. .

Abstract

Carney complex (CNC) is an inherited tumor predisposition associated with pituitary tumors, including GH-producing pituitary adenomas and rare reports of prolactinomas. This disease is caused by mutations in PRKAR1A, which encodes the type 1A regulatory subunit of the cAMP-dependent protein kinase, PKA. Loss of PRKAR1A causes enhanced PKA signaling, which leads to pituitary tumorigenesis. Mutations in the gene have not been detected in sporadic pituitary tumors, but there is some data to suggest that non-genomic mechanisms may cause loss of protein expression. Unlike CNC patients, mice heterozygous for Prkar1a mutations do not develop pituitary tumors, although complete knockout of the gene in the Pit1 lineage of the pituitary produces GH-secreting pituitary adenomas. These data indicate that complete loss of Prkar1a/PRKAR1A is able to cause pituitary tumors in mice and men. The pattern of tumors is likely related to the signaling pathways employed in specific pituitary cell types.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histopathology of pituitary tumors from Prkar1a-PitKO mice. A. Hematoxylin and eosin staining of a pituitary showing the presence of 2 microadenoms (white arrows). B. Mitotic figures (yellow arrows) observed within a different pituitary tumor. Scale bars are indicated for each panel.
Figure 2
Figure 2
Model for the connection between PRKAR1A mutations and acromegaly. A. The primary signaling pathways connecting hypothalamic signaling to pituitary hormone secretion are indicated for each cell type of the Pit1 lineage. See text for references. Note that Somatotrophs are primarily dependent on cAMP/PKA signaling for this process. B. Loss of PRKAR1A or activation of Gsα can cause secretion of GH independent of upstream signals.
See this image and copyright information in PMC

References

    1. Carney JA. Carney complex: the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas. Semin Dermatol. 1995;14:90–8. - PubMed
    1. Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab. 2001;86:4041–6. - PubMed
    1. Bertherat J. Carney complex (CNC) Orphanet J Rare Dis. 2006;1:1–6. - PMC - PubMed
    1. Bertherat J, Horvath A, Groussin L, Grabar S, Boikos S, Cazabat L, Libe R, Rene-Corail F, Stergiopoulos S, Bourdeau I, Bei T, Clauser E, Calender A, Kirschner LS, Bertagna X, Carney JA, Stratakis CA. Mutations in regulatory subunit type 1A of cyclic adenosine 5′-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab. 2009;94:2085–91. - PMC - PubMed
    1. Boikos SA, Stratakis CA. Carney complex: the first 20 years. Curr Opin Oncol. 2007;19:24–9. - PubMed

MeSH terms

Substances